Clinical Trial Update: Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating adding sodium valproate to standard EGFR monoclonal antibody therapy for metastatic colorectal cancer and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• EGFR monoclonal antibody (standard-of-care) (EGFR monoclonal antibody)
• Sodium valproate (valproate)

Snippet

Sponsor: Australasian Gastro-Intestinal Trials Group | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING